ArticleHistopathology2025

Current practice of pathologic response assessment following chemoimmunotherapy for non-small cell lung cancer (NSCLC) in Germany: first real-world data from the multicentre Re-GraDE study.

Felix Elsner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.